“…Inspired by the structures and functions of metalloenzymes, tremendous efforts have been exerted to develop site-selective C–H bond oxidation reactions utilizing biomimetic nonheme manganese and iron complexes combined with a variety of artificial oxidants, such as H 2 O 2 , iodosylbenzene (PhIO), and peracids . Notably, White and co-workers have detailed elegant results employing nonheme iron and manganese complexes possessing rigid tetradentate nitrogen ligands (PDP and CF 3 -PDP; PDP = 1,1′-bis(pyridin-2-ylmethyl)-2,2′-bipyrrolidine, CF 3 -PDP = 1,1′-bis((5-(2,6-bis(trifluoromethyl)phenyl)pyridin-2-yl)methyl)-2,2′-bipyrrolidine) that are capable of oxidizing the distal methine C–H bonds in a predictable manner on the basis of a combination of electronic, steric, and stereoelectronic differences of multiple C–H bonds and the methylene C–H bonds through catalyst control. , More recently, polarity reversal and noncovalent interactions between catalysts and substrates have been utilized to modulate the selectivity in nonheme iron- and manganese complex-catalyzed site- and/or stereoselective C–H bond oxidations. , Despite significant recent advances, , some drawbacks of currently available methods for C(sp 3 )–H oxidation are the laborious synthesis of the chelating ligand, low turnover numbers, superstoichiometric amounts of oxidant, long reaction time, and recycling and recovery of starting material to obtain satisfactory product yields.…”